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Summary
p120 catenin is thought to be a key regulator of
E-cadherin function and stability, but its role(s) in
vivo is poorly understood. To examine these directly,
we generated a conditional p120 knockout mouse
and targeted p120 ablation to the embryonic salivary
gland. Surprisingly, acinar differentiation is completely
blocked, resulting in a gland composed entirely of
ducts. Moreover, p120 ablation causes E-cadherin de-
ficiency in vivo and severe defects in adhesion, cell
polarity, and epithelial morphology. These changes
closely phenocopy high-grade intraepithelial neopla-
sia, a condition that, in humans, typically progresses
to invasive cancer. Tumor-like protrusions appear
immediately after p120 ablation at e14 and expand
into the lumen until shortly after birth, at which time
the animals die with completely occluded glands. The
data reveal an unexpected role for p120 in salivary
acinar development and show that p120 ablation by
itself induces effects consistent with a role in tumor
progression.
Introduction
Cadherins play essential roles in development, tissue
morphogenesis, and cancer (Gumbiner, 2005; Takeichi,
1995). Epithelial (E)-cadherin is the main cell-cell adhe-
sion molecule in epithelial tissues and is regarded as
a master organizer of the epithelial phenotype. In many
cancers, E-cadherin dysfunction or downregulation is
closely linked to the metastatic phenotype and poor pa-
tient prognosis (Birchmeier and Behrens, 1994; Frixen
et al., 1991; Vleminckx et al., 1991). These observations
underpin wide interest in E-cadherin and the proteins
that regulate its roles in development and cancer.
Key regulators of E-cadherin are p120-catenin and
b-catenin, cytoplasmic Armadillo repeat proteins with
roles in cell-cell adhesion, signal transduction, and
gene expression (Anastasiadis and Reynolds, 2000; Nel-
son and Nusse, 2004; Van Roy and McCrea, 2005).
Whereas b-catenin mediates the physical association
of E-cadherin with the actin cytoskeleton, p120 controls
the strength of cell-cell adhesion by regulating cadherin
stability and retention at the cell surface (Davis et al.,
2003; Xiao et al., 2003). Mechanistic studies in vitro indi-
cate that this cadherin-stabilizing activity occurs at the
posttranslational level and requires direct p120 interac-
tion with the cadherin cytoplasmic tail (Ireton et al.,
2002). p120 is also an important modulator of RhoGT-
*Correspondence: al.reynolds@vanderbilt.eduPases, which may, in part, explain its roles in regulating
cadherin stability and/or cadherin clustering (Anasta-
siadis et al., 2000; Grosheva et al., 2001; Magie et al.,
2002; Noren et al., 2000). In addition, p120 interacts
with the transcription factor Kaiso (Daniel and Reynolds,
1999; Prokhortchouk et al., 2001), which belongs to
a POZ family of proteins implicated in development
and cancer. Recent advances in Xenopus reveal roles
for p120 and Kaiso in both canonical and noncanonical
Wnt signaling (Kim et al., 2004; Park et al., 2005) and
a functional interdependency between Kaiso/p120 and
TCF/b-catenin complexes in the regulation of Wnt sig-
naling pathways (Park et al., 2005). All of these observa-
tions suggest roles for p120 in development and cancer.
Interestingly, an extensive pathology literature indi-
cates that regional loss or downregulation of p120 oc-
curs frequently in essentially all of the major human can-
cers (Thoreson and Reynolds, 2002). Thus, p120
downregulation in vivo may be important in tumor pro-
gression, but the presence of multiple other genetic and
epigenetic defects in such tumors has complicated ef-
forts to understand its role in human cancer.
In mammals, p120 has three close family members
(i.e., ARVCF, d-catenin, p0071), which have at least
partly redundant functions because they can rescue
cadherin stability in vitro in p120-deficient cell lines
(Davis et al., 2003). Remarkably, the effects of knocking
out the lone p120 homolog in Drosophila and C. elegans
are relatively minor (Myster et al., 2003; Pettitt et al.,
2003). In mice, conventional gene knockouts of p120
family members ARVCF (Armadillo gene deleted in
Velo-CardioFacial syndrome) (R. Kuperlapati, personal
communication) or d-catenin (Israely et al., 2004) result
in viable animals with either unremarkable (ARVCF) or
behavioral (d-catenin) phenotypes. In contrast, Xenopus
p120 (xp120) and xARVCF are essential genes whose in
vivo knockdown by morpholino technology causes gas-
trulation defects and death (Fang et al., 2004). Likewise,
conventional p120 knockout in mice is early embryonic
lethal (A.B.R., unpublished data) despite the potential
in mammals for rescue by family members. Whether re-
dundancy in mice is important in vivo at the individual
tissue level is unknown.
To directly examine the in vivo consequences of p120
ablation, we have generated a conditional p120 knock-
out mouse and targeted p120 ablation to the developing
submandibular gland (SMG). Surprisingly, acinar differ-
entiation is completely blocked, resulting in a gland
made up entirely of ducts. In the ducts and in the epithe-
lia of several other organs examined, p120 ablation dra-
matically reduces E-cadherin levels and causes severe
defects in epithelial morphology and adhesion. The ap-
pearance of dysplasia, cell shedding, and dramatic epi-
thelial masses is concurrent with p120 ablation, indicat-
ing a direct causal relationship. By parturition, ductal
lumina are completely occluded by largely unpolarized
epithelial masses that retain the ability to proliferate
and escape apoptosis. The adhesive and morphologic
abnormalities are indistinguishable from high-grade in-
traepithelial neoplasia (IEN), a precancerous condition
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veloping invasive cancer. The data indicate an essential
role for p120 in salivary acinar differentiation and show
that, in vivo, p120 downregulation by itself has important
cancer-relevant consequences in various epithelia. These
observations reveal striking in vivo consequences of
p120 ablation and are consistent with a tumor sup-
pressor role that is at least partly due to its cadherin-
stabilizing function.
Results
Generation of a Conditional p120 Knockout Mouse
To study the role of p120 in vivo, we used Cre/lox tech-
nology to generate a conditional p120 knockout mouse
(see Figure S1 in the Supplemental Data available with
this article online). The p120 gene was isolated from an
RPCI-22 (120S6/SvEvTac) Mouse BAC Library (Osoe-
gawa et al., 2000) and sequenced. To create a condition-
ally null allele, loxP sites were introduced into introns 2
and 8. Deletion of the floxed segment removes the four
natural in-frame ATGs, causing an early frame shift and
termination of translation. The targeting construct was
stably transfected into 129SvEvTac ES cells, and
G418-resistant colonies were selected. Clones with ho-
mologous recombination at the p120 gene locus were
identified by Southern blotting (data not shown). The
Neo/TK cassette was removed in vitro by transient
transfection of FlpE recombinase and Gancyclovir
selection. ES technology was then used to produce
germline homozygous mice. Homozygous p120-floxed
animals (f/f) displayed no overt phenotype, and embry-
onic fibroblasts (MEFs) derived from these animals ex-
pressed p120 levels and isoform patterns that were
identical to those from wild-type MEFs (Figure S1D).
These data indicate that the floxed p120 gene is ex-
pressed and spliced normally.
To examine the consequences of p120 loss in vivo, we
chose an MMTV-Cre-based conditional knockout strat-
egy aimed initially at targeting p120 ablation to the mam-
mary gland epithelia. Although E-cadherin ablation is
tolerated in MMTV-Cre mice (Boussadia et al., 2002),
our animals died shortly after birth. Normal Mendelian
ratios of offspring were observed at birth, but only 2 of
100 animals survived to weaning, and most animals
died within 24 hr of parturition. The cause of death could
not be definitively identified.
Preliminary analysis of newborn MMTV-Cre; p120-
floxed mice revealed p120 ablation targeted specifically
to the epithelial compartment of the salivary glands, the
lachrymal gland, and skin. p120 expression was normal
in all other tissues. In skin, p120 loss was relatively inef-
ficient; approximately 50% of cells in the epidermis and
hair follicles exhibited p120 knockout. By contrast, p120
knockout in epithelia of the salivary glands (both the
SMG and SLG) was virtually complete in w98% of ani-
mals analyzed; the remaining 2% showed variable de-
grees of mosaic p120 retention. Because SMG morpho-
genesis occurs between e11 and birth, we were able to
analyze the effects of p120 ablation over the entire
course of glandular development before the animals
died. The sublingual gland (SLG) develops alongside
and was invariably fused to the SMG in the tissue ana-lyzed, but most of the data were similar to those ob-
tained for the SMG and are therefore not shown.
Absence of Acini and Severe Morphologic Defects
in the Salivary Glands
Examination of the fully formed wild-type and knockout
SMGs just after birth revealed striking consequences of
p120 ablation (Figure 1). Figures 1A and 1C show the
presence and absence of p120 immunofluorescent
staining in wild-type and knockout SMGs, respectively.
The entire SMG is shown at low magnification to illus-
trate the complete loss of p120 in all epithelial compart-
ments throughout the knockout gland. The areas of
bright staining in Figure 1C are autofluorescent signals
generated by red blood cells.
Hemotoxylin and eosin (H&E) staining (Figures 1B and
1D) revealed a complete absence of the exocrine com-
partment (acini) in the p120 knockout SMG (Figure 1D)
and SLG (data not shown) glands. The normal SMG
(Figure 1B) consists mostly of secretory acini, which
are responsible for making saliva. Acini are organized
into lobules (Figure 1B, boxed), which make up over
80% of the gland and are drained by ducts (white arrow-
head) into the oral cavity. In contrast to normal SMGs,
the knockout glands lacked acini and consisted entirely
of misshapen ducts.
Strikingly, the ductal systems in all newborn SMGs
examined (n > 20) were poorly organized, and they are
grossly distended by lumen-filling epithelial masses
(Figure 1D, arrows) and large numbers of nonadhesive
cells. These cellular masses (Figure 1D, arrows) invari-
ably led to ductal occlusion by birth. Thus, p120 ablation
in the SMG blocked acinar differentiation entirely and
caused major defects in duct epithelial morphology.
Reduced E-Cadherin in p120 Null Ducts
Since siRNA-induced p120 downregulation in vitro
causes cadherin instability (Davis et al., 2003), we asked
whether the in vivo morphologic and/or adhesive de-
fects in p120-ablated ducts might be associated with re-
duced E-cadherin levels. Although p120 expression in
the SMG ducts was completely absent in the vast major-
ity of experimental animals, a few pups contained ran-
dom patterns of mosaic p120 expression. To directly
compare p120-positive and -negative tissue on the
same tissue section, these mosaic animals were double
labeled by immunofluorescence with antibodies to p120
and E-cadherin (Figure 2). p120-positive regions
(arrows) serve as internal positive controls for p120-
negative tissue (arrowheads). Importantly, p120 ablation
dramatically reduced E-cadherin levels in vivo (Figures
2A–2C). Note that in areas where epithelial structure
was not completely disrupted (e.g., Figure 2C, arrow-
head), E-cadherin was reduced by about 50% or more
but remained localized to cell-cell junctions. a-catenin
(data not shown) and b-catenin levels (Figures 2D and
2E) were also reduced in proportion to E-cadherin, con-
sistent with prior evidence that a- and b-catenins are di-
rectly stabilized by cadherin binding (Nagafuchi et al.,
1991). Despite reduced E-cadherin, b-catenin was not
observed in the cytoplasm or nucleus.
To determine whether p120 ablation was acting
selectively on the adherens junction, mosaic SMG sec-
tions were colabeled with antibodies to p120 and
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during Development of the Salivary Gland
(A–D) Consequence of p120 knockout in the
submandibular salivary gland (SMG) at day
1 postpartum (1 dpp). (A and B) Wild-type
and (C and D) knockout SMGs from 1 dpp
pups were stained by immunofluorescence
for (A and C) p120 or by H&E to examine gross
morphology. The entire gland is shown at
low magnification. Note that p120 staining is
completely absent from the epithelium of
knockout glands (the bright areas in (C) are
autofluorescence from red blood cells).
Wild-type SMGs are composed mostly of ac-
ini (black arrowhead) that are organized into
lobes (boxed in [B]) and drain into ducts
(white arrowhead) that empty into the mouth.
(D) In knockout SMGs, the acinar compart-
ments are completely absent, and dilated
misshapen ducts are completely occluded
by shed cells and massive epithelial out-
growth (arrow).desmoglein-I, a desmosomal cadherin that does not as-
sociate with p120 (Figures 2G–2I), or the tight junction
protein occludin (data not shown). In all areas where ep-
ithelial structure was not completely disrupted (e.g.,
Figure 2H, arrowhead), desmoglein and occludin levels
were unaffected by p120 loss, indicating that the in
vivo effect of p120 loss is selective for the E-cadherin
complex and does not alter the levels of other junctional
proteins.
On the other hand, there were prominent foci through-
out the gland where epithelial structure was completely
disrupted. These foci or nodules expanded rapidly from
e14 until birth, and all of the ducts in mutant SMGs were
eventually occluded by large epithelial masses that pro-
truded into the lumen (e.g., Figures 2G–2I, dotted circle;
Figures 1D and 6D–6F). All junctional components in
these structures were severely mislocalized, indicating
complete breakdown of epithelial cell polarity.
To determine whether p120 ablation had similar ef-
fects on E-cadherin in other tissues, we examined
p120 mosaic sections from skin (Figures 2J–2L) and
lachrymal gland (Figures 2M–2O), the two other tissues
targeted in these animals by the MMTV-Cre transgene.
As in the SMG, E-cadherin levels were dramatically re-
duced in p120-negative regions (arrowheads) of both
tissues. In similar experiments with villin-Cre mice con-
ducted to target p120 ablation to the small intestine
and colon, E-cadherin levels were also reduced by
more than 50% (data not shown). Although N-cadherin
was not expressed in the SMG epithelium, P-cadherin
levels were reduced slightly by p120 ablation (data not
shown). Interestingly, P-cadherin localized selectively
to the basal cell layer of the ducts in the wild-type glands
and was barely detectable in the luminal cells and
acini (data not shown). These data reveal that p120 is
essential for E-cadherin stability in vivo in many epithe-
lial tissues. Other adherens junction cadherins (e.g.,
P-cadherin) may be affected as well, as has been dem-
onstrated previously in cell lines (Davis et al., 2003),but the reduction of P-cadherin levels was not as
obvious.
Morphologic Defects and Epithelial Outgrowths
Are Directly Due to p120 Ablation
To distinguish between immediate and secondary ef-
fects of p120 ablation, we sought to determine the tem-
poral relationship between p120 loss and the pheno-
types observed in the 1 dpp knockout glands. Glands
were isolated at different stages (e13.5–1 dpp) and
were analyzed by H&E staining (Figure 3). Whereas
wild-type and knockout glands were identical at e13.5
(Figures 3A and 3B), all subsequent stages revealed
striking differences. e14.5 glands were misshapen and
contained prematurely dilated lumens, small ductal
masses, and large numbers of shed cells (compare Fig-
ures 3C and 3D). Ductal masses increased in size at ev-
ery stage and completely occluded duct lumena by 1
dpp. Wild-type ducts were well formed and never con-
tained shed cells. Acini were prominent by e17.5 in
wild-type glands, but were notably absent from knock-
out glands (Figures 3G and 3H), a condition that per-
sisted at birth (Figures 3I and 3K). To definitively distin-
guish between misshapen ducts and acini in the 1 dpp
glands, wild-type and knockout SMGs were immunola-
beled with the SMG-specific acinar marker Muc-10
(compare Figures 3K and 3L). The near complete ab-
sence of Muc-10 staining confirms at the molecular level
the failure of acinar differentiation.
The striking difference between wild-type and knock-
out glands at e14.5 correlated exactly with the onset of
MMTV-Cre expression and p120 ablation between
e13.5 and e14.5. The status of p120 and E-cadherin ex-
pression at these stages was evaluated in detail by co-
staining e13.5 and e14.5 glands for p120 and E-cadherin
(Figure 4). In the knockout SMG, p120 staining was nor-
mal or subtly reduced at e13.5 (Figures 4D and 4F), but
it was completely absent by e14.5 (Figures 4J and 4L).
Thus, p120 expression in the mutant animals is normal
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In Vivo
(A–O) Samples with unusual mosaic p120 ex-
pression were intentionally selected to facili-
tate internal comparison of p120-positive
and -negative tissue. Note that levels of E-
cadherin and b-catenin, but not Desmoglein
1, are dramatically reduced in p120-negative
regions. Tissue sections from (A–I) neonatal
SMGs, (J–L) neonatal back skin, and (M–O)
adult lachrymal gland were coimmuno-
stained for (A, D, G, J, and M) p120 and either
(B, K, and N) E-cadherin, (E) b-catenin, or (H)
Desmoglein 1 (Dsg1). Arrows point to p120-
positive cells and to the corresponding cells
costained for E-cadherin, b-catenin, or Dsg1.
Arrowheads point to p120-negative cells
and to corresponding costained counter-
parts. Note the diffuse staining of Dsg1 and
the loss of cell polarity in early epithelial out-
growth (circled in [G]–[I]).for the first two days of SMG development (up to
we13.5) and is then extinguished for the remainder of
the developmental program. Importantly, premature
lumen dilation, ductal outgrowth, and cell shedding
coincided precisely with p120 ablation. Thus, obvious
changes in cell morphology and adhesion were immedi-
ate consequences of p120 ablation.
p120 Is Required for Normal Epithelial Polarization
and Morphogenesis during Tubulogenesis
Tube morphogenesis (tubulogenesis) during develop-
ment of the duct system in exocrine glands involves de
novo establishment and maintenance of epithelial polar-
ity, a process that, in turn, requires E-cadherin (Hogan
and Kolodziej, 2002). Interestingly, p120 (and E-cad-
herin) expression in the wild-type gland was strongly el-
evated by e14.5 in regions of nascent duct formation
(Figure 4M), and the rise and intensity of p120 and E-
cadherin staining was precisely coordinated (e.g., com-
pare Figures 4G and 4H), an observation consistent with
p120’s critical role in stabilizing cadherin levels.
To examine the role of p120 at the level of duct and ep-
ithelial morphogenesis, e14.5 glands were immuno-
stained with classic epithelial polarity markers for apical(Crb3) and basolateral (NaK-ATPase) membrane do-
mains (Figures 4M–4P). Figures 4M and 4O reveal
sharply delineated but intermittent Crb3 staining mark-
ing future lumena in the wild-type ducts. The images
capture in midstream the process of establishing an api-
cal surface. The intermittent Crb3 staining in presump-
tive ducts becomes contiguous with time and leads to
the formation of a patent lumen. Coincident with the
appearance of Crb3, p120 levels (Figure 4M) and NaK-
ATPase levels (Figure 4O) increased markedly as
apicobasal polarity was established. Previous in vitro
mechanistic studies reveal clearly that p120 stabilizes
E-cadherin, not the other way around (Davis et al.,
2003; Ireton et al., 2002). Thus, from a mechanical per-
spective, the functional elevation of E-cadherin neces-
sary for establishment and maintenance of epithelial
cell polarity is likely codependant on the presence and
increase in p120. Indeed, these events were seriously
compromised in p120 knockout glands. p120 was lost
between e13.5 and e14.5, and E-cadherin levels were
dramatically diminished at e14.5, but not at e13.5 (com-
pare Figures 4F and 4L). In the e14.5 knockout glands,
both luminal (Crb3) and basolateral (NaK-ATPase) polar-
ity markers were badly mislocalized in presumptive
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Gland Morphogenesis
(A–J) H&E staining of wild-type and knockout
SMG sections from (A and B) e13.5, (C and D)
e14.5, (E and F) e15.5, (G and H) e17.5, and (I
and J) 1 dpp embryos. Wild-type and knock-
out SMGs are identical at e13.5. Note the
striking changes at e14.5 (premature lumen
dilation; cell shedding, white arrowhead;
early epithelial outgrowth, arrow). Ductal out-
growths/masses appear at e14.5 and in-
crease in size (arrows in [D], [F], [H], and [J])
until birth (1 dpp), at which time ducts are
completely occluded. (G and H) Acini (black
arrowhead) appear in (G) wild-type SMGs at
e17.5, but are absent from (H and J) knockout
SMGs.
(K and L) 1 dpp wild-type and knockout SMGs
were stained with antibodies to MUC-10,
a specific marker for embryonic acini. (L)
Note the near complete absence of acinar
staining in the knockout gland.ducts (Figure 4P), indicating severe mechanical defects
during this process of tube morphogenesis. These
changes coincided precisely with premature and exag-
gerated dilation of the ductal lumen and aberrant cell
shedding (Figures 4N and 4P), suggesting that all of
these defects are immediate consequences of p120 loss.
Epithelial Dysplasia, Defective Cell-Cell Adhesion,
and Lumen Occlusion
Normal neonatal ducts are well-ordered bilaminate
structures consisting of basal and luminal epithelial
cell layers (Figure 5A). In contrast, 1 dpp p120 knockout
ducts displayed a number of severe abnormalities that
were indistinguishable in most respects from high-
grade intraepithelial neoplasia, a precancerous condi-
tion in humans that usually progresses to become inva-
sive. Knockout ducts were tortuous (Figure 5B), and the
normally stratified epithelium was instead pseudostrati-
fied and badly organized, with nuclear elongation and
crowding (Figure 5D). The severe disorganization in the
epithelial bilayer was highlighted by staining with anti-
bodies to p63, a specific (nuclear) marker for the basal
cell layer (Figures 5E and 5F). The basal layer was always
contiguous in normal ducts, but mutant ducts contained
vast epithelial expanses in which p63-positive basal
cells were absent (Figure 5F, arrows). Although basal
cells are normally never in contact with the lumen, p63
staining revealed a severe mixing of the layers and
even luminal shedding of basal cells (Figure 5E, arrow-
head). These defects were also highlighted by Crb3
staining, which was linear and contiguous in the wild-type gland (Figure 5E, green), but usually broken and/
or scalloped in the mutant gland (Figure 5F, green).
The most striking defect manifested as a complete
breakdown of epithelial polarity in the tumor-like epithe-
lial masses found in all SMG lumina after e14.5 (Figure 6).
As evident from the stage progression shown in Figure 3,
the masses appeared as nodules immediately upon
p120 ablation (e14.5) and increased in size until the ani-
mals died shortly after birth (1 dpp). Interestingly, stain-
ing with the classic polarity markers Crb3 (luminal) and
NaK-ATPase (basolateral) revealed that the growths
(i.e., Figures 6D–6H) differed markedly from the rest
of the affected epithelium. Specifically, although all of
the epithelium was highly disordered, the growths dis-
played complete loss of epithelial polarity, whereas, in
most other areas, epithelial polarity was largely retained.
For example, Figures 6C and 6F show the proper local-
ization of Crb3 and p120, or Crb3 and NaK-ATPase, in
the wild-type gland. Note that Crb3 and Na ATPase are
invariably present and contiguous in wild-type ducts.
Likewise, in the knockout glands, apical Crb3 and baso-
lateral NaK-ATPase staining localized properly in most
areas despite p120 absence (Figures 6D–6H). Thus, ep-
ithelial polarity is maintained in most of the neonatal
SMG ducts despite reduced E-cadherin levels and se-
vere epithelial disorganization. In contrast, epithelial po-
larity breaks down completely in epithelial masses and
shed cells (e.g., Figures 6D–6H, arrowheads).
It is worth noting that although we focused on the sal-
ivary gland, dramatic changes in morphology and adhe-
sion were also observed in the lachrymal glands of the
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lishment of Apicobasal Polarity and Normal
Tubulogenesis during Nascent Duct Forma-
tion
(A–L) Precise timing and analysis of p120 ab-
lation. Wild-type and knockout SMGs from
(A–F) e13.5 and (G–L) e14.5 animals were co-
stained for p120 and E-cadherin as indicated.
Note the p120 upregulation at the center of
both (A) e13.5 and (G) e14.5 presumptive
ducts (arrows) and the concurrent upregula-
tion of E-cadherin. p120 depletion occurs be-
tween e13.5 and e14.5 (see [F] and [J]).
(M–P) Effect of p120 ablation on epithelial cell
polarization and nascent duct formation.
Wild-type and knockout e14.5 glands were
costained with (M and N) p120 and apical
marker Crb3 or with (O and P) basolateral
marker NaK-ATPase and Crb3. (M and O)
p120 and NaK-ATPase staining is strongly
upregulated in the ductal epithelium (arrows)
and is low in the end buds (arrowheads). (N
and P) In the knockout ducts, the absence
of p120 causes severe mislocalization of po-
larity markers (half arrows), aberrant lumen
dilation, cell shedding, and epithelial protru-
sion/outgrowth into the lumen.handful of mosaic animals that survived to adulthood
(Figure S2). Effects of p120 loss in the lachrymal gland
included absence of prominent basal lamina, collapsed
lumina with loss of cell and nuclear polarity, coarsely
vacuolated cytoplasm, and large gaps reflecting poor
cell-cell adhesion.
Persistent Cell Proliferation and Low Apoptotic
Rates in Epithelial Masses
Under normal circumstances, prolonged separation
from the basal lamina might be expected to block prolif-
eration and/or increase apoptosis rates by anoikas.
However, the epithelial masses did not give rise to cellu-
lar debris and/or cell death, but instead became increas-
ingly prominent until the animals died shortly after birth.
To assess the proliferation and apoptotic status within
the luminal masses, we assayed both parameters
throughout SMG development by BrdU and TUNEL
staining. Results from 1 dpp sections are shown (Fig-
ure 7). BrdU labeling (Figures 7A and 7B) revealed verysimilar rates of cell proliferation in the wild-type (4.5 6
0.8% of duct cells) and mutant glands (4.8% 6 0.9% of
duct cells). (Quantitative comparison was for duct cells
only since acini failed to appear in p120-ablated glands).
In the wild-type gland, proliferating cells were found pri-
marily in the basal layer. We were unable to assess the
relative distribution of proliferating cells in the mutant
glands, however, because ubiquitous mixing of the layers
made it impossible to accurately assign cells to one
layer or the other. Importantly, it was clear that epithelial
masses frequently contained proliferating cells (arrow-
head, Figure 7B).
Interestingly, mutant SMGs (1 dpp) exhibited apopto-
sis rates as much as 10-fold greater than wild-type
glands (28.5 6 4.6 versus 2.8 6 0.8, respectively, p =
0.0001). The effect was first noticed at e14.5, suggesting
that it was directly due to p120 ablation. However, apo-
ptotic figures did not concentrate in the luminal masses,
but were instead scattered throughout the gland. Thus,
there was little indication of high rates of apoptosis in
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27Figure 5. p120 Ablation Induces Morpho-
logic Features of High-Grade Intraepithelial
Neoplasia
(A–F) The epithelial organization of (A, C, and
E) wild-type and (B, D, and F) knockout 1 dpp
salivary glands were analyzed by (A–D) H&E
staining or (E and F) immunofluorescent
staining. (A–D) (A and B) Typical wild-type
and knockout ducts are illustrated at low
magnification. (C and D) Boxed regions are
magnified to illustrate morphologic abnor-
malities. In wild-type ducts, note the orga-
nized bilayer with regularly spaced and
shaped nuclei, patent lumina lacking shed
cells, and the well-formed apical surfaces.
(D) In contrast, knockout ducts are highly dis-
organized with aberrant morphology, nuclear
crowding, and irregular nuclear size, shape,
and polarity (arrow). Apical surfaces are scal-
loped, and they contain numerous budding
cells (arrowhead) that frequently lose adhe-
sion altogether (note the healthy shed cells
in the lumen). (E and F) Defective organization
of the basal cell layer. Wild-type and knock-
out ducts were costained with the apical
membrane marker Crb3 (green) and the basal
cell marker p63 (red) in order to track the fate
of basal cells in the knockout epithelium.
Cells were counterstained with the DNA dye
DAPI, which stains nuclei blue. (F) p63 stain-
ing reveals a striking disruption of bilaminate
architecture (arrows), with severe mislocali-
zation and even luminal shedding (arrow-
head) of basal cells. The magnification in
(A)–(D) is 633.the luminal masses despite the abnormal localization
and behavior of these structures.
Discussion
We have used conditional p120 ablation in the mouse
embryonic salivary gland to examine the consequences
of p120 loss in vivo. The results reveal an essential unex-
pected role in acinar differentiation and striking defects
in cell-cell adhesion and morphology. Remarkably, p120
ablation by itself induces changes indistinguishable in
most respects from high-grade intraepithelial neoplasia,
a condition that, in humans, usually progresses to inva-
sive cancer.
The consequence of p120 loss in most tissues is more
severe than initially expected. For example, we are not
aware of other MMTV-Cre-targeted gene deletions that
cause early lethal phenotypes. Also, we have recently
targeted p120 ablation to the epithelium of the small in-
testine and colon. These animals bleed out into the co-
lon and die between 15 and 25 days after birth because
of massive adhesion defects and epithelial shedding
(A.B.R., unpublished data). Thus, with the exception of
epidermis, where adhesive defects are minor (data not
shown), in vivo tissue-specific p120 ablation typically
causes profound and sometimes lethal alterations.
Importantly, we find that p120 is essential for E-
cadherin stability in vivo. E-cadherin downregulation is
clearly a general in vivo effect of p120 loss, as it has
been observed in all organs analyzed to date. In vitro
studies have established already that this phenomenonis not due to transcriptional or translational effects. In-
stead, when nascent E-cadherin protein arrives at the
cell surface, it must directly interact with p120 or it is im-
mediately internalized and degraded (Ireton et al., 2002).
Although we did not attempt to rescue E-cadherin levels
in vivo, high-level E-cadherin overexpression in cultured
cells can efficiently rescue the adhesive defects associ-
ated with p120 loss (Ireton et al., 2002). In addition, most
of the adhesive and morphologic effects are consistent
with previously established in vivo consequences of
E-cadherin deficiency. For example, in the absence of
p120, tubulogenesis and lumen formation during sali-
vary gland development was markedly impaired. Also,
most of the other p120 null tissues we evaluated dis-
played morphologic and adhesive defects, and E-
cadherin levels fell by at least 50% in the salivary
glands, the lachrymal gland, and the epidermis. Thus,
it is likely that many of the observed morphologic effects
result from inadequate E-cadherin levels.
An important question only partly addressed is
whether the effects of p120 loss are due primarily to
E-cadherin deficiency, or, alternatively, to other con-
sequences of p120 loss. Recent evidence in Xenopus
implicates p120 in canonical and noncanonical Wnt
signaling (Kim et al., 2004; Park et al., 2005), and p120
ablation in various cell lines (A.B.R., unpublished data)
and in keratinocytes in vivo (E. Fuchs, personal commu-
nication) results in constitutive activation of Rho. As
mentioned, however, the striking morphologic and
adhesive defects induced by p120 deficiency in vitro
can be efficiently rescued by forced overexpression of
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of Epithelial Polarity in Luminal Masses
(A and B) H&E-stained sections of wild-type
and knockout SMGs. (B) shows a small epi-
thelial mass of rounded nonpolarized cells
(white arrowhead).
(C–H) Analysis of epithelial polarity with clas-
sic apical (Crumbs3, Crb3) and basolateral
(NaK-ATPase, NaK) cell markers. Wild-type
and knockout neonatal salivary glands were
costained for (C–E) p120 (green) and Crb3
(red) or for (F–H) NaK-ATPase (green) and
Crb3 (red). Note the severe mislocalization
of both apical (Crb3) and basolateral (NaK)
markers in focal areas of ductal outgrowth
(white arrowheads) in both (D and G) SMG
and (E and H) SLG ducts. (D–H) In contrast,
most of the p120-negative epithelium main-
tains structural and functional epithelial po-
larity despite severe disorganization (see
Figure 5D).wild-type E-cadherin, and even p120-uncoupled E-cad-
herin mutants (Ireton et al., 2002). These data argue that
likely mechanistic intermediates such as Rho, and p120
itself, are largely dispensable if the physical requirement
for adequate cadherin levels is met artificially by other
means. In addition, we have not been able to rescue E-
cadherin stability in vitro in p120-ablated cells by forced
expression of dominant active and/or negative Rho or
Rac mutants. Nonetheless, Rho-GTPases have impor-
tant effects on adherens junctions and on cell prolifera-
tion, and p120 ablation can disrupt Rho-GTPase signal-
ing in some cell types. Thus, it is likely that E-cadherin
deficiency is just one of many factors contributing to
these phenotypes.Surprisingly, acinar differentiation in the SMG is
completely blocked. Although tracing the exact cause
of this defect is beyond the scope of this report, the
data suggest that, like b-catenin, p120 may have deter-
mining roles in key developmental signaling pathways.
Given the recently described roles for p120/Kaiso in ca-
nonical and noncanonical Wnt signaling, it is possible
that acinar differentiation fails in p120 knockout animals
because p120 is required to derepress Kaiso-mediated
roles in Wnt signaling (Kim et al., 2004; Park et al.,
2005). Interestingly, the two female animals in our study
that survived past puberty failed to develop mammary
ductal trees (data not shown), suggesting that p120
may also be essential for differentiation decisions inFigure 7. Analysis of Proliferation and Apo-
ptosis in Ductal Outgrowths
(A and B) Analysis of cell proliferation in duc-
tal outgrowths. Neonatal SMG sections were
stained for BrdU incorporation. There was
no difference in the total number of BrdU-
positive nuclei in wild-type versus knockout
salivary glands (data not shown). However,
ductal outgrowths contained BrdU-positive
nuclei (black arrowhead), indicating contin-
ued proliferation despite mislocalization and
separation from basal lamina. Note that pro-
liferative cells in wild-type glands are con-
tained in the basal layer.
(C and D) Analysis of apoptosis in ductal out-
growths. Neonatal (1 dpp) SMG sections
were immunostained for p120 (green) and
TUNEL (red). Knockout salivary glands ex-
hibit a 10-fold increase in apoptosis com-
pared to wild-type glands. However, TUNEL
staining is widespread and rarely concen-
trated in ductal outgrowths (white arrow-
heads).
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Of possible relevance is that LEF-12/2 mice lack mam-
mary glands and also die at birth (van Genderen et al.,
1994). Other possible mechanisms include defects in
Rho signaling, and/or disruption of a broad range of ep-
ithelial-mesenchymal interactions and signaling events
that are known to influence terminal differentiation of
endbuds in other systems (Hogan and Kolodziej, 2002;
Lubarsky and Krasnow, 2003; Wang and Laurie, 2004).
These pathways vary from organ to organ and are only
partially elucidated in the salivary gland.
The striking requirement for p120 at the individual tis-
sue/organ level in mice contrasts sharply with the fact
that p120 is not essential in C. elegans or Drosophila
(Myster et al., 2003; Pettitt et al., 2003), even though
these organisms lack potentially redundant p120 family
members. Interestingly, sequence alignments and other
criteria indicate that the fly/worm p120 homolog is prob-
ably d-catenin, suggesting that p120, per se, evolved
later. In mice, ARVCF and d-catenin are also nonessen-
tial genes, and the consequences of their knockouts are
not obviously related to E-cadherin function. It appears
from these data that evolution has favored p120 as the
dominant family member for regulating E-cadherin in
mice, though it is not yet clear whether this reflects rel-
ative abundance and/or issues related to tissue-specific
expression patterns, or whether the different family
members have evolved important variations in function.
Regardless, while p120 family members may account
for the partial retention of E-cadherin after p120 ablation
in vivo, they are either unable or not sufficiently abun-
dant to effectively counteract p120 ablation in the sali-
vary gland, lachrymal gland, small intestine, or colon. In-
terestingly, xARVCF and xp120 are both essential in
Xenopus and can cross rescue one another in repletion
experiments, suggesting significant functional overlap
(Fang et al., 2004). Direct comparison to our data, how-
ever, is difficult because gastrulation defects (and
death) in Xenopus preclude later analysis at the tissue
and organ level. It is worth mentioning that p120 is not
essential at the level of individual cells. Its absence in
some cells may in fact support or increase cell prolifera-
tion in several cell types due to Rho activation and
downstream effects on various signaling pathways, in-
cluding NFkB and the cell cycle machinery. Like E-
cadherin, however, p120 is clearly indispensable for
the integrity and proper function of most epithelia both
in vivo and in vitro.
Based on the prominent role of p120 in stabilizing E-
cadherin, we postulated previously that p120 might it-
self have tumor and/or metastasis suppressor activity.
Despite an extensive pathology literature on p120 down-
regulation in tumors (Thoreson and Reynolds, 2002),
there is little consensus as to whether this might in fact
be the case. Interestingly, a recent siRNA-based screen
for novel tumor suppressors turned up d-catenin as one
of 25 candidate genes selected objectively for the ability
to suppress epithelial transformation (Westbrook et al.,
2005). d-catenin was in fact one of eight genes constitut-
ing over 90% of the hits. Although the early death of our
animals precluded long-term follow up and/or direct as-
sessment of tumor suppressor activity, our experiments
show clearly that in vivo p120 downregulation by itself
induces high-grade intraepithelial neoplasia. Regard-less of the exact mechanism, this observation suggests
strongly that p120 downregulation induces similar ef-
fects in human tumors. In combination with various ge-
netic abnormalities typically found in tumors, such ef-
fects are likely to play an important role in malignancy.
E-cadherin downregulation in tumors is widely be-
lieved to trigger the transition to metastasis. Whether
p120 downregulation promotes tumor progression or
metastasis has not been established, but in vivo experi-
ments with dominant-negative (DN)-cadherins argue
in favor of the idea. We and others have shown that
DN-cadherin overexpression works primarily by seques-
tering p120 and thereby inducing downregulation of
endogenous cadherins (reviewed in Reynolds and Car-
nahan, 2004). Interestingly, DN-cadherin expression in
the mouse small intestine causes adenomas (Hermiston
and Gordon, 1995), and, in the RipTag2 mouse model of
pancreatic cancer, DN-cadherin strongly promotes me-
tastasis (Perl et al., 1998). These effects were attributed
to E-cadherin dysfunction, but are more likely the direct
consequence of DN-cadherin-induced p120 deficiency.
Consistent with this, several studies have emerged that
link p120 downregulation to poor patient prognosis
(Bremnes et al., 2002; Gold et al., 1998; Kallakury et al.,
2001; Wijnhoven et al., 2005). Our data show clearly
that p120 ablation by itself has dire consequences that
include and closely resemble many effects of E-cadherin
downregulation. However, the relative in vivo effects of
E-cadherin downregulation by well established mecha-
nisms (e.g., mutation, promotor methylation, transcrip-
tional repression), as opposed to E-cadherin deficiency
caused by p120 downregulation, may differ markedly
with respect to cell/tumor behavior and patient progno-
sis because consequences of p120 deficiency, perhaps
related to Rho and/or Wnt signaling, could contribute
additional effects important for tumorigenesis. Regard-
less of the exact mechanism(s), it is now clear that in
vivo p120 downregulation by itself induces prominent
effects consistent with a key role in tumor progression.
Experimental Procedures
Generation of Targeting Construct
Genomic DNA for murine p120 was obtained by screening the RPCI-
22 (129S6/SvEvTac) mouse BAC library with a cDNA probe gener-
ated against full-length murine p120, isoform 1A. PCR-generated in-
tronic probes were amplified from p120-containing BAC clones and
were used to screen a shotgun library of HindIII-digested BAC frag-
ments; the region spanning intron 2–exon 15 (Figure 1A) was se-
quenced.
To generate the Neo-TK selection cassette, TK was removed from
the pPNT vector by EcoR1-HindIII digestion, and it was then inserted
immediately downstream of the Neo cassette of pM30. The targeting
construct was pieced together from p120 genomic fragments. It be-
gins at the second PshA1 site upstream of exon 3 and ends with the
PmlI site after exon 15. The selection cassette containing Neo, TK,
and the 50 LoxP site was inserted into the first PshA1 site upstream
of exon 3. The 30 LoxP site was inserted into an Asc1 site generated
between two BbvC1 sites in intron 8.
Strains and Breeding
Chimeric animals carrying the floxed p120 allele (f) on the
129SvEvTac background were bred to the Black-Swiss outbred
line for germline transmission. Germline animals were crossed
once to the R26r Cre-reporter line (r) on a C57/Bl-6 background. An-
imals were bred to homozygosity for f/f, r/r mice. We crossed f/f, r/r
mice with heterozygous floxed p120 mice carrying a Cre allele (f/+,
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Tac:Black-Swiss floxed p120 animals to homozygosity (f/f), and then
breeding these to MMTV-Cre animals (Wagner et al., 1997) on a C57/
Bl-6 background. Only F1 animals from the (f/f, r/r)3 (f/+, Cre) cross
were analyzed.
Generation of Floxed p120 Mice
The targeting construct illustrated in Figure S1 was linearized with
NotI and electroporated into 129SvEvTac ES cells. Stable integrants
were selected with G418. A total of 25 homologous integrants were
identified by screening 384 KpnI-digested G418-resistant clones
with a 681 bp PCR-generated probe (50-CTTGTGCTGTTATTTG
GTGACTGG-30 to 50-CGTCTGTAATCCCTCTGCTTGTGAG-30) (see
Figure S1A). Six clones were chosen for FlpE-mediated recombina-
tion to remove the selection cassette and were negatively selected
with gancyclovir. Resistant clones were screened by PCR, and 3 re-
combinants were isolated from nearly 1000 clones screened. All
three clones were generated from the same parental G418-resistant
ES cell clone. Using standard procedures, one ES cell clone was
used to successfully generate a founder line.
Genotyping was accomplished by PCR. The primers for MMTV-
Cre have been described previously (Wagner et al., 1997). The 30
LoxP site for p120 was identified with 50-TTTTAGAGCCTCCCACA
TACAAGC-30 and 50-TCAGCACCCACACAAAGGTTG-30, which iden-
tified a 322 bp wild-type allele and a 365 bp floxed allele (Figure S1B),
while the 50 LoxP site was identified with 50-TTGAACTCAGGACCGT
CAGAGGAG-30 and 50-AAAGCAAGCCACCACCAACC-30 to identify
a 450 bp wild-type and a 564 bp floxed allele (Figure S1C). The 50
LoxP primer set was used routinely for genotyping.
Immunohistochemistry
Tissues were fixed in formalin overnight at 4ºC. Paraffin-embedded
sections (5 mm) were prepared for H&E staining, PAS staining, and
immunohistochemistry (IHC). For IHC, we used sodium citrate anti-
gen retrieval for all antibodies but occludin and BrdU. Antigen re-
trieval for occludin was achieved by incubating sections in 1 mg/
ml protease (Sigma P5147) for 10 min at 37ºC. For fluorescent IHC,
samples were incubated with primary and secondary antibodies
overnight at 4ºC and for 2 hr at room temperature, respectively. Sec-
tions were mounted with Prolong Antifade Mounting Medium (Mo-
lecular Probes #P7481). We visualized staining on a Zeiss Axioplan
2 microscope and collected images with Open Lab software (Impro-
vision) and a Hamamatsu Orca-ER digital camera (#CA742-95); all
images were pseudocolored. Nonfluorescent IHC used standard
techniques.
We stained sections with the following primary antibodies: rabbit
anti-p120 (F1aSH, 1:400 [Thoreson et al., 2000]); anti-p120 Catenin/
pp120 (#610133, 1:400) and anti-E-cadherin (#610181, 1:500) from
BD Transduction Laboratories; anti-b-catenin (#C2206, 1:800) and
anti-a-catenin (#C2066, 1:800) from Sigma; Na+, K+-ATPase (Upstate
Biotechnology #05-369, 1:1000); Desmoglein 1 (Santa Cruz, #sc-
20114; 1:200); occludin (Zymed #71-1500, 1:50); BrdU (Accurate
Chemical & Scientific Corp. #OBT0030, 1:400); anti-mouse neutro-
phil (Serotec #MCA771GA, 1:150); and Crumbs 3 (kind gift from
Ben Margolis, Ann Arbor, MI, 1:400 [Makarova et al., 2003]). Apopto-
tic events were detected with the ApopTag Fluorescein In Situ Apo-
ptosis Detection kit (Chemicon # S7110). Secondary antibodies,
conjugated to either the 488 Alexa-fluor or the 594 Alexa-fluor,
were obtained from Molecular Probes.
Supplemental Data
Supplemental Data including design and characterization of the
p120 conditional knockout mouse (Figure S1) and morphologic anal-
ysis of p120 null lachrymal glands (Figure S2) are available at http://
www.developmentalcell.com/cgi/content/full/10/1/21/DC1/.
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